Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.
2.

Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC).

Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, Berrino F, Tjønneland A, Bigaard J, Olsen A, Overvad K, Clavel-Chapelon F, Nagel G, Boeing H, Trichopoulos D, Economou G, Bellos G, Palli D, Tumino R, Panico S, Sacerdote C, Krogh V, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Amiano P, Pera G, Quirós JR, Martínez C, Tormo MJ, Wirfält E, Berglund G, Hallmans G, Key TJ, Reeves G, Bingham S, Norat T, Biessy C, Kaaks R, Riboli E.

Int J Cancer. 2004 Sep 20;111(5):762-71.

3.

[Body mass index and cancer incidence:a prospective cohort study in northern China].

Guo L, Li N, Wang G, Su K, Li F, Yang L, Ren J, Chang S, Chen S, Wu S, He J, Dai M.

Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Mar;35(3):231-6. Chinese.

PMID:
24831616
4.

Several anthropometric measurements and breast cancer risk: results of the E3N cohort study.

Tehard B, Clavel-Chapelon F.

Int J Obes (Lond). 2006 Jan;30(1):156-63.

5.

[Anthropometry and female breast cancer: a prospective cohort study in urban Shanghai].

Li HL, Gao YT, Li Q, Liu DK.

Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Jun;27(6):488-93. Chinese.

PMID:
17152508
6.

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk.

van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, Rohan T, Smith-Warner SA, Speizer FE, Willett WC, Wolk A, Hunter DJ.

Am J Epidemiol. 2000 Sep 15;152(6):514-27.

PMID:
10997541
7.

Height, weight weight change, and postmenopausal breast cancer risk: The Netherlands Cohort Study.

van den Brandt PA, Dirx MJ, Ronckers CM, van den Hoogen P, Goldbohm RA.

Cancer Causes Control. 1997 Jan;8(1):39-47.

PMID:
9051321
8.

Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.

Fagherazzi G, Chabbert-Buffet N, Fabre A, Guillas G, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F.

Int J Obes (Lond). 2012 Mar;36(3):431-9. doi: 10.1038/ijo.2011.66. Epub 2011 Mar 22.

PMID:
21427693
9.

Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women.

de Lignières B, de Vathaire F, Fournier S, Urbinelli R, Allaert F, Le MG, Kuttenn F.

Climacteric. 2002 Dec;5(4):332-40.

PMID:
12626212
10.

Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.

Suzuki R, Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, Shimazu T, Tsugane S; Japan Public Health Center-based Prospective Study Group.

Int J Cancer. 2011 Sep 1;129(5):1214-24. doi: 10.1002/ijc.25744. Epub 2011 Apr 8.

11.

Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.

Dartois L, Fagherazzi G, Baglietto L, Boutron-Ruault MC, Delaloge S, Mesrine S, Clavel-Chapelon F.

Int J Cancer. 2016 May 15;138(10):2415-27. doi: 10.1002/ijc.29987. Epub 2016 Feb 4.

12.

Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).

Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson J, Margolis KL, Muti PC, Stefanick ML, McTiernan A.

Cancer Causes Control. 2002 Oct;13(8):741-51.

PMID:
12420953
13.

Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study.

Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):220-4.

14.

Body weight and risk of breast cancer in BRCA1/2 mutation carriers.

Manders P, Pijpe A, Hooning MJ, Kluijt I, Vasen HF, Hoogerbrugge N, van Asperen CJ, Meijers-Heijboer H, Ausems MG, van Os TA, Gomez-Garcia EB, Brohet RM; HEBON, van Leeuwen FE, Rookus MA.

Breast Cancer Res Treat. 2011 Feb;126(1):193-202. doi: 10.1007/s10549-010-1120-8. Epub 2010 Aug 21.

PMID:
20730487
15.
16.

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.

Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F.

Int J Cancer. 2005 Apr 10;114(3):448-54.

17.

Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.

Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE, Folsom AR, Sellers TA.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):656-61.

18.

Body shape throughout life and the risk for breast cancer at adulthood in the French E3N cohort.

Fagherazzi G, Guillas G, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S.

Eur J Cancer Prev. 2013 Jan;22(1):29-37. doi: 10.1097/CEJ.0b013e328355ec04.

PMID:
22694827
19.

A prospective study of body size and breast cancer in black women.

Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1795-802.

20.

Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States.

Galanis DJ, Kolonel LN, Lee J, Le Marchand L.

Cancer Causes Control. 1998 Mar;9(2):217-24.

PMID:
9578299

Supplemental Content

Support Center